Annual SGA
$6.13 M
-$994.90 K-13.96%
September 30, 2024
Summary
- As of February 25, 2025, SONN annual SGA is $6.13 million, with the most recent change of -$994.90 thousand (-13.96%) on September 30, 2024.
- During the last 3 years, SONN annual SGA has fallen by -$2.81 million (-31.40%).
- SONN annual SGA is now -31.40% below its all-time high of $8.94 million, reached on September 30, 2021.
Performance
SONN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.96 M
-$11.20 K-0.57%
December 31, 2024
Summary
- As of February 25, 2025, SONN quarterly SGA is $1.96 million, with the most recent change of -$11.20 thousand (-0.57%) on December 31, 2024.
- Over the past year, SONN quarterly SGA has stayed the same.
- SONN quarterly SGA is now -29.39% below its all-time high of $2.78 million, reached on September 30, 2020.
Performance
SONN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$464.12 M
-$9.43 M-2.07%
December 31, 2024
Summary
- As of February 25, 2025, SONN TTM SGA is -$464.12 million, with the most recent change of -$9.43 million (-2.07%) on December 31, 2024.
- Over the past year, SONN TTM SGA has dropped by -$471.56 million (-6337.61%).
- SONN TTM SGA is now -500.08% below its all-time high of -$77.34 million.
Performance
SONN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SONN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.0% | 0.0% | -6337.6% |
| 3 y3 years | -31.4% | 0.0% | -6337.6% |
| 5 y5 years | +144.3% | 0.0% | -6337.6% |
SONN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | at low | -15.2% | +200.4% | -99.3% | at low |
| 5 y | 5-year | -31.4% | +144.3% | -29.4% | +200.4% | -500.1% | at low |
| alltime | all time | -31.4% | +144.3% | -29.4% | +200.4% | -500.1% | at low |
Sonnet BioTherapeutics Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $1.96 M(-0.6%) | $7.44 M(+21.4%) |
| Sep 2024 | $6.13 M(-14.0%) | $1.97 M(+9.6%) | $6.13 M(+3.0%) |
| Jun 2024 | - | $1.80 M(+5.9%) | $5.95 M(+4.5%) |
| Mar 2024 | - | $1.70 M(+160.3%) | $5.69 M(-3.1%) |
| Dec 2023 | - | $653.50 K(-63.6%) | $5.88 M(-17.5%) |
| Sep 2023 | $7.13 M(-16.9%) | $1.79 M(+16.3%) | $7.13 M(-6.8%) |
| Jun 2023 | - | $1.54 M(-18.1%) | $7.65 M(-8.8%) |
| Mar 2023 | - | $1.88 M(-1.0%) | $8.38 M(-0.2%) |
| Dec 2022 | - | $1.90 M(-17.8%) | $8.40 M(-2.0%) |
| Sep 2022 | $8.58 M | $2.32 M(+1.6%) | $8.58 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $2.28 M(+20.0%) | $8.65 M(-0.8%) |
| Mar 2022 | - | $1.90 M(-8.6%) | $8.73 M(-3.3%) |
| Dec 2021 | - | $2.08 M(-13.2%) | $9.02 M(+0.9%) |
| Sep 2021 | $8.94 M(+18.6%) | $2.39 M(+1.8%) | $8.94 M(-4.1%) |
| Jun 2021 | - | $2.35 M(+7.1%) | $9.33 M(-1.4%) |
| Mar 2021 | - | $2.20 M(+9.9%) | $9.46 M(+12.1%) |
| Dec 2020 | - | $2.00 M(-28.1%) | $8.44 M(+31.0%) |
| Sep 2020 | $7.53 M(+200.3%) | $2.78 M(+11.9%) | $6.44 M(+76.0%) |
| Jun 2020 | - | $2.48 M(+111.4%) | $3.66 M(+211.4%) |
| Mar 2020 | - | $1.18 M | $1.18 M |
| Sep 2019 | $2.51 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual SGA?
- What is the all time high annual SGA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual SGA year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly SGA?
- What is the all time high quarterly SGA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly SGA year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM SGA?
- What is the all time high TTM SGA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM SGA year-on-year change?
What is Sonnet BioTherapeutics Holdings annual SGA?
The current annual SGA of SONN is $6.13 M
What is the all time high annual SGA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual SGA is $8.94 M
What is Sonnet BioTherapeutics Holdings annual SGA year-on-year change?
Over the past year, SONN annual SGA has changed by -$994.90 K (-13.96%)
What is Sonnet BioTherapeutics Holdings quarterly SGA?
The current quarterly SGA of SONN is $1.96 M
What is the all time high quarterly SGA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly SGA is $2.78 M
What is Sonnet BioTherapeutics Holdings quarterly SGA year-on-year change?
Over the past year, SONN quarterly SGA has changed by $0.00 (0.00%)
What is Sonnet BioTherapeutics Holdings TTM SGA?
The current TTM SGA of SONN is -$464.12 M
What is the all time high TTM SGA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM SGA is -$77.34 M
What is Sonnet BioTherapeutics Holdings TTM SGA year-on-year change?
Over the past year, SONN TTM SGA has changed by -$471.56 M (-6337.61%)